CoVac-1 Induces T-Cell Responses in Patients With B-Cell Deficiencies

CoVac-1, a peptide-based COVID-19 vaccine, induced T-cell responses in patients with B-cell deficiencies.

Related Keywords

Germany ,Claudia Tandler ,Juliane Walz ,University Hospital ,Cancer Therapy Advisor ,